All these novel findings on the role of ZBP1 as a key player in innate immunity present promising opportunities to interfere with inflammatory cell death to improve treatment options in infectious diseases and cancer and suggest the ZBP1 RHIM domains (Figure 1B) as promising targets to mediate cellular processes in a variety of pathologies. The gene discussed is ZBP1; the disease is infectious disease.